MEKanistic Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5M

  • Investors
  • 2

MEKanistic Therapeutics General Information

Description

Operator of a biotechnology company intended to develop cancer therapeutics. The company uses computational tools to design medications used to block key pathways to signal cancer cell growth, enabling patients to access multi-compound treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1015 Glenwood Avenue
  • Fourth Floor
  • Minneapolis, MN 55405
  • United States
+1 (612)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1015 Glenwood Avenue
  • Fourth Floor
  • Minneapolis, MN 55405
  • United States
+1 (612)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MEKanistic Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 02-Jun-2022 $5M Completed Pre-Clinical Trials
4. Grant 01-Sep-2021 Completed Startup
3. Early Stage VC 12-Mar-2019 Completed Startup
2. Grant 01-Feb-2017 $275K Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view MEKanistic Therapeutics’s complete valuation and funding history, request access »

MEKanistic Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view MEKanistic Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MEKanistic Therapeutics Patents

MEKanistic Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230133958-A1 Compounds useful in modulating egfr and pi3k Inactive 20-Oct-2021
US-11673876-B2 Substituted aminobenzyl heteroaryl compounds as egfr and/or pi3k inhibitors Active 22-Dec-2020
US-20220213054-A1 Substituted aminobenzyl heteroaryl compounds as egfr and/or pi3k inhibitors Active 22-Dec-2020
US-20240239764-A1 Substituted aminobenzyl heteroaryl compounds as egfr and/or pi3k inhibitors Pending 22-Dec-2020 C07D401/04

MEKanistic Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MEKanistic Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invenshure Accelerator/Incubator Minority
U.S. Department of Health and Human Services Government
To view MEKanistic Therapeutics’s complete investors history, request access »

MEKanistic Therapeutics FAQs

  • When was MEKanistic Therapeutics founded?

    MEKanistic Therapeutics was founded in 2015.

  • Where is MEKanistic Therapeutics headquartered?

    MEKanistic Therapeutics is headquartered in Minneapolis, MN.

  • What is the size of MEKanistic Therapeutics?

    MEKanistic Therapeutics has 7 total employees.

  • What industry is MEKanistic Therapeutics in?

    MEKanistic Therapeutics’s primary industry is Drug Discovery.

  • Is MEKanistic Therapeutics a private or public company?

    MEKanistic Therapeutics is a Private company.

  • What is the current valuation of MEKanistic Therapeutics?

    The current valuation of MEKanistic Therapeutics is .

  • What is MEKanistic Therapeutics’s current revenue?

    The current revenue for MEKanistic Therapeutics is .

  • How much funding has MEKanistic Therapeutics raised over time?

    MEKanistic Therapeutics has raised $6.86M.

  • Who are MEKanistic Therapeutics’s investors?

    Invenshure and U.S. Department of Health and Human Services have invested in MEKanistic Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process